Become a part of our success!
Our vision is to create a world where cancer is diagnosed early and treated successfully. We are pleased to announce that we have launched a new investment campaign in which […]
EIC & EuroQuity – Bpifrance Healthcare Investor Day
It was my great pleasure to present Glycanostics® and our early-stage cancer diagnostic test Giasay® at the EIC & EuroQuity – Bpifrance Healthcare Investor Day on 23 October in Paris. It was a great […]
HealthTech Innovation Days (HTID) – HealthTech For Care
„Glycanostics® is going to be one of 25 most innovative companies that will compete at a pitch competition at the HealthTech Innovation Days (HTID®) in Paris. Please meet our CEO […]
European Angel Investment Summit 2023
Meet our CEO Eva Kovacova FCCA at the European Angel Investment Summit in Brussels on 10-11 October! Join me at the premier annual conference where angels, entrepreneurs, and change-makers come together to […]
We are expanding the network of cooperating urologists
The network of urologists who provide the Giasay® PROSTATE test is gradually expanding. Today, you can take the highly accurate prostate cancer test at specialist urology clinics in four regional […]
EUROPEAN PATENT – EP3775909
First Patent Certificate for EP Patent No. 3 775 909 for us! Availabe here.
New project: € 2.5 mil. funding signed for Novel serological glycan-based biomarkers for screening of breast, lung and pancreatic cancers
The Glycanostics cancer screening technology detects glycan changes (complex carbohydrates) attached to a protein in the blood. It is highly scalable due to the following unique characteristics: detects early-stage cancers […]
European Female Founders Summit
8th & 9th March, 2023, Brussels Our CEO Eva Kováčová is one of the organisers of the first summit by the EU Female Founders in Brussels under the sponsorship of […]
ISO 13485
Glycanostics took another important step to improve its quality management system and has been granted with ISO 13485.
